
Ben Diamond, MD
@bendiamondmd
Assistant Professor, Myeloma Institute @SylvesterCancer. Former @MSKCancerCenter chief fellow. Opinions expressed are my own.
ID: 1052927638149484545
18-10-2018 14:21:26
355 Tweet
784 Followers
253 Following

Amazing science & discussion at 2nd Annual Translational & Clinical Oncology symposium today at Sylvester Comprehensive Cancer Center University of Miami in beautiful Miami. Thank you all speakers! The Leukemia & Lymphoma Society ASH Multiple Myeloma RF International Myeloma Foundation HealthTree Foundation Jason Luke, MD, FACP Stephen D. Nimer, MD Dan Landau FDA Oncology #asco


Excited to share new pre-print from the lab! Ben Diamond, MD investigated 580 WGS to define the mutagenic impact of radiotherapy in hematological malignancies. Great collaboration between Heidelberg Myeloma Moffitt Cancer Center Sylvester Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center 1/19


We're excited to share this work a long time in the making! It took a village. Big thanks to all of our collaborators at home and abroad! Heidelberg Myeloma Sylvester Comprehensive Cancer Center Moffitt Cancer Center Memorial Sloan Kettering Cancer Center

Ben Diamond, MD and Francesco Maura in collaboration with Dr Pourbrahim and Holly Lee presenting in CD38 mutations and deletions in mediating resistance to anti-CD38 antibodies with differential effect in some of these mutations of isa vs dara #ASH24


#ASH24 update: BCMA and GPRC5D are not alone anymore. CD38 gene loss may lead to antigen escape and resistance to anti-CD38 antibodies in some myeloma patients Congratulations Francesco Maura Ben Diamond, MD ! #mmsm


Just before the holidays, new preprint from the lab on bioRxiv! Super talented Ben Diamond, MD reports CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma #mmsm Great collaboration with Heidelberg Myeloma Mayo Clinic University of Miami U Calgary Sanofi Myeloma 👇👇🧵 1/13



Join us at the Lymphoma, Leukemia & Myeloma Winter Symposium! Learn from Sylvester experts Drs. C. Ola Landgren, M.D., Craig Moskowitz, MD, Mikkael A. Sekeres MD, MS & Ben Diamond, MD as they share insights on the latest advancements. Register ➡️ loom.ly/1lyNso4



And that's a wrap on #MyelomaMRD2025! We just heard from Ben Diamond, MD, David Coffey & Hans Lee (MD Anderson Cancer Center), who highlighted exciting new MRD technologies emerging in myeloma! Sylvester Comprehensive Cancer Center #mmMRD #MMsm


Happy to share our editorial and thoughts about the AQUILA trial recently published in NEJM. Thanks Leif Bergsagel for involving me in this effort! 🙏 #msmm Memorial Sloan Kettering Cancer Center MSK Department of Medicine Mayo Clinic nejm.org/doi/full/10.10…


Great experience working with the team Blood Cancer Discovery !

Our CD38 resistance story is out in Blood Journals Portfolio. We had a great time putting this one together. Big multi-institutional collab!


Our lab fantastic postdoc Juanjo Garcés will present today our study on CTC in multiple myeloma @mmsm. Several relevant findings by linking WGS, RNAseq and CTC. Great collaboration with Tomas Jelinek Ben Diamond, MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Memorial Sloan Kettering Cancer Center UNIVERSITY OF OSTRAVA ECON/SOC/ENVIRON HISTORY University of Miami Multiple Myeloma RF #mmsm

Biallelic Antigen Escape is a Mechanism of Resistance to Anti-CD38 Antibodies in MM - Francesco Maura Blood Journals Portfolio Ben Diamond, MD Linda B. Baughn Mayo Myeloma Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 nizar jacques bahlis Shaji Kumar Marc S. Raab oncodaily.com/science/anti-c… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter


Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma [May 10, 2024] Ross Firestone et al. @BloodJournal ashpublications.org/blood/article/… #CARTcell #ImmunoOnc #mmsm HT Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma [May 10, 2024] <a href="/RossFirestone/">Ross Firestone</a> et al. @BloodJournal
ashpublications.org/blood/article/… #CARTcell #ImmunoOnc #mmsm HT <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a> Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma [May 10, 2024] <a href="/RossFirestone/">Ross Firestone</a> et al. @BloodJournal
ashpublications.org/blood/article/… #CARTcell #ImmunoOnc #mmsm HT <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a>](https://pbs.twimg.com/media/GuyDUi8XkAAKv1B.jpg)

🚨 New paper in Nature Genetics ! How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-related myeloid neoplasms? We uncovered this process through single-colony WGS! See the full paper here! nature.com/articles/s4158…

NEW STUDY ONLINE Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific Antibodies #mmsm International Myeloma Foundation Multiple Myeloma RF HealthTree Foundation ASH Sylvester Comprehensive Cancer Center University of Miami ashpublications.org/bloodadvances/…